Sahajanand Medical Technologies Ltd Falls 1.75%: 5 Key Factors Behind the Weekly Decline
2026-11-21 09:00:10Key Events This Week 16 Nov: New 52-week and all-time high at Rs.578.10 17 Nov: Moderate gains amid rising Sensex 18 Nov: Price correction with Sensex decline 19 Nov: Further decline despite Sensex rally 20 Nov: Week closes lower at Rs.525.85 (-1.75%) Week OpenRs.543.45 Week Close...
Read More
Sahajanand Medical Technologies Ltd is Rated Sell
2026-11-16 10:11:45Sahajanand Medical Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Broad-Based Technical Strength Lifts Sahajanand Medical Technologies Ltd to 52-Week High of Rs 578.1
2026-11-16 10:06:16Surging to an all-time high of Rs 578.1 on 16 Nov 2026, Sahajanand Medical Technologies Ltd has demonstrated remarkable price momentum, outpacing its sector and riding a wave of technical signals that point to sustained strength.
Read More
Sahajanand Medical Technologies Ltd Hits All-Time High of Rs 578.1 as Momentum Builds Across Timeframes
2026-11-16 09:41:15Extending its winning streak to four consecutive sessions, Sahajanand Medical Technologies Ltd surged to a fresh all-time high of Rs 578.1 on 16 Nov 2026, outperforming its sector and the broader market with a day gain of 2.73% against the Sensex's 0.68% rise.
Read MoreSahajanand Medical Technologies Gains 1.76%: 2 Key Events Shaping the Week
2026-11-14 09:00:10Key Events This Week 09 Nov: Intraday low amid price pressure (Rs.504.75) 13 Nov: Intraday high with 7.25% surge (Rs.541) 13 Nov: Week closes at Rs.535.20 (+1.76%) Week OpenRs.525.95 Week CloseRs.535.20+1.76% Week High</...
Read More
Sahajanand Medical Technologies Surges 7.25% to Day's High of Rs 541 — Outperforms Sector by 7.01 Percentage Points
2026-11-13 12:04:23While the Sensex declined by 0.47% on 13 Nov 2026, Sahajanand Medical Technologies surged 7.25%, marking a standout session in the Healthcare Services sector with a 7.01 percentage-point outperformance. This sharp intraday rally rewrites the short-term narrative for the mid-cap stock, raising questions about the sustainability and technical implications of this move.
Read More
Sahajanand Medical Technologies Hits Intraday Low Amid Price Pressure
2026-11-09 11:22:49Sahajanand Medical Technologies experienced a notable intraday decline on 09 Nov 2026, with its stock price touching a low of Rs 504.75, reflecting a 5.52% drop. This downturn occurred despite the stock trading above all key moving averages, signalling immediate price pressure amid a broader market reversal.
Read MoreSahajanand Medical Technologies Gains 14.35%: Key Drivers Behind the Week’s Rally
2026-11-07 09:00:10Key Events This Week 2 Nov: Stock opens at Rs.459.85, marginal decline amid strong Sensex rally 4 Nov: Sharp 5.93% jump to Rs.485.85, signalling renewed buying interest 5 Nov: Shift to sideways momentum amid mixed technical signals 6 Nov: Intraday high of Rs.531.5 with 7.41% close-to-close gain Week OpenRs.459.95 Week Close...
Read More
Sahajanand Medical Technologies Surges 7.41% to Day's High of Rs 531.5 — Outperforms Sector by 7.38 Percentage Points
2026-11-06 12:32:54The Sensex rose 0.92% on 6 Nov 2026, yet Sahajanand Medical Technologies outpaced the broader market with a 7.41% gain, touching an intraday high of Rs 531.5. This 7.38-percentage-point outperformance over its Healthcare Services sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.
Read MoreIntimation Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015
20-Nov-2026 | Source : BSEAppointment of MUFG Intime India Private Limited as the Registrar & Share Transfer Agent of the Company w.e.f. October 23 2026 (Date of Listing)
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10-Nov-2026 | Source : BSESchedule of Analyst/Investor Meet
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
08-Nov-2026 | Source : BSETranscript of Earnings Call for Q2 & H1 FY27 Financial Results held on Thursday November 05 2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available